{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:13:38Z","timestamp":1790313218794,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s12272-012-0321-6","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T04:04:20Z","timestamp":1333512260000},"page":"393-396","source":"Crossref","is-referenced-by-count":36,"title":["Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases"],"prefix":"10.1007","volume":"35","author":[{"given":"Kyung-Min","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,5]]},"reference":[{"key":"321_CR1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","volume":"389","author":"M. J. Caterina","year":"1997","unstructured":"Caterina, M. J., The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 389, 816\u2013824 (1997).","journal-title":"Nature"},{"key":"321_CR2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","volume":"288","author":"M. J. Caterina","year":"2000","unstructured":"Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I., and Julius, D., Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 288, 306\u2013313 (2000).","journal-title":"Science"},{"key":"321_CR3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2007.06.006","volume":"132","author":"B. A. Chizh","year":"2007","unstructured":"Chizh, B. A., The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain, 132, 132\u2013141 (2007).","journal-title":"Pain"},{"key":"321_CR4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1523\/JNEUROSCI.5150-09.2010","volume":"30","author":"A. Garami","year":"2010","unstructured":"Garami, A., Shimansky, Y. P., Pakai, E., Oliveira, D. L., Gavva, N. R., and Romanovsky, A. A., Contributions of different modes of TRPV1 activation to TRPV1 antagonistinduced hyperthermia. J. Neurosci., 30, 1435\u20131440 (2010).","journal-title":"J. Neurosci."},{"key":"321_CR5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","volume":"136","author":"N. R. Gavva","year":"2008","unstructured":"Gavva, N. R., Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain, 136, 202\u2013210 (2008).","journal-title":"Pain"},{"key":"321_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2004.12.007","volume":"378","author":"T. Iida","year":"2005","unstructured":"Iida, T., Shimizu, I., Nealen, M. L., Campbell, A., and Caterina, M., Attenuated fever response in mice lacking TRPV1. Neurosci. Lett., 378, 28\u201333 (2005).","journal-title":"Neurosci. Lett."},{"key":"321_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0960-894X(02)01040-5","volume":"13","author":"H. G. Park","year":"2003","unstructured":"Park, H. G., Park, M. K., Choi, J. Y., Choi, S. H., Lee, J., Park, B. S., Kim, M. G., Suh, Y. G., Cho, H., Oh, U., Kim, H. D., Park, Y. H., Koh, H. J., Lim, K. M., Moh, J. H., and Jew, S. S., Synthesis of N,N,N-trisubstituted thiourea derivatives and their antagonist effect on the vanilloid receptor. Bioorg. Med. Chem. Lett., 13, 601\u2013604 (2003).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"321_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpba.2011.11.011","volume":"61","author":"Y. H. Park","year":"2012","unstructured":"Park, Y. H., Joo, K. M., Woo, B. Y., Son, E. D., Byun, S. Y., Shin, H. J., Lee, K. W., Park, Y. H., and Lim, K. M., Oral and topical pharmacokinetic studies of a novel TRPV1 antagonist, PAC-14028 in rats and minipigs using liquid chromatography\/tandem mass spectrometric method. J. Pharm. Biomed. Anal., 61, 8\u201314 (2012).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"321_CR9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/ajrccm\/137.6.1330","volume":"137","author":"A. Saria","year":"1988","unstructured":"Saria, A., Martling, C. R., Yan, Z., Theodorsson-Norheim, E., Gamse, R., and Lundberg, J. M., Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am. Rev. Respir Dis., 137, 1330\u20131335 (1988).","journal-title":"Am. Rev. Respir Dis."},{"key":"321_CR10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nn942","volume":"5Suppl","author":"J. Scholz","year":"2002","unstructured":"Scholz, J. and Woolf, C. J., Can we conquer pain? Nat. Neurosci., 5 Suppl, 1062\u20131067 (2002).","journal-title":"Nat. Neurosci."},{"key":"321_CR11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.jid.5700231","volume":"126","author":"M. Steinhoff","year":"2006","unstructured":"Steinhoff, M., Bienenstock, J., Schmelz, M., Maurer, M., Wei, E., and B\u00edr\u00f3, T., Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J. Invest. Dermatol., 126, 1705\u20131718 (2006).","journal-title":"J. Invest. Dermatol."},{"key":"321_CR12","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1021\/jm0502790","volume":"48","author":"Y. G. Suh","year":"2005","unstructured":"Suh, Y. G., Lee, Y. S., Min, K. H., Park, O. H., Kim, J. K., Seung, H. S., Seo, S. Y., Lee, B. Y., Nam, Y. H., Lee, K. O., Kim, H. D., Park, H. G., Lee, J., Oh, U., Lim, J. O., Kang, S.U., Kil, M. J., Koo, J. Y., Shin, S. S., Joo, Y. H., Kim, J. K., Jeong, Y. S., Kim, S. Y., and Park, Y. H., Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents. J. Med. Chem., 48, 5823\u20135836 (2005).","journal-title":"J. Med. Chem."},{"key":"321_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrd2280","volume":"6","author":"A. Szallasi","year":"2007","unstructured":"Szallasi, A., Cortright, D. N., Blum, C. A., and Eid, S. R., The vanilloid receptor TRPV1, 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov., 6 357\u2013372 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"321_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/pr.110.002725","volume":"62","author":"L. J. Wu","year":"2010","unstructured":"Wu, L. J., Sweet, T. B., and Clapham, D. E., International union of basic and clinical pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol. Rev., 62, 381\u2013404 (2010).","journal-title":"Pharmacol. Rev."},{"key":"321_CR15","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/jid.2011.87","volume":"131","author":"J. W. Yun","year":"2011","unstructured":"Yun, J. W., Seo, J. A., Jang, W. H., Koh, H. J., Bae, I. H., Park, Y. H., and Lim, K. M., Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models. J. Invest. Dermatol., 131, 1576\u20131579 (2011a).","journal-title":"J. Invest. Dermatol."},{"key":"321_CR16","first-page":"8","volume":"62","author":"J. W. Yun","year":"2011","unstructured":"Yun, J. W., Seo, J. A., Jeong, Y. S., Bae, I. H., Jang, W. H., Lee, J., Kim, S. Y., Shin, S. S., Woo, B. Y., Lee, K. W., Lim, K. M., and Park, Y. H., TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. J. Dermatol. Sci., 62, 8\u201315 (2011b).","journal-title":"J. Dermatol. Sci."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-012-0321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-012-0321-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-012-0321-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T16:36:54Z","timestamp":1559579814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-012-0321-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s12272-012-0321-6","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}